Long-Term Outcomes in 10-Year Survivors of Early-Stage Hodgkin Lymphoma
The progression-free survival benefit of radiotherapy (RT) in patients with early-stage Hodgkin lymphoma (HL) has been affirmed by numerous prospective trials. However, concerns regarding late RT effects have resulted in a decline in the use of RT in recent years. We aimed to investigate differences in overall survival (OS) among 10-year survivors of early-stage HL to further elucidate long-term treatment risks.
Source: International Journal of Radiation Oncology * Biology * Physics - Category: Radiology Authors: J.E. Bates, N.P. Mendenhall, R.T. Hoppe, L.S. Constine, B.S. Hoppe Tags: Oral Abstracts Source Type: research